At a time when gynecologic minimally invasive surgery has become relatively mature, the significance of robotic platforms should not be simply understood as a replacement for laparoscopy. For most routine cases, laparoscopy remains a stable, accessible, and relatively cost-controllable basic approach. Based on our clinical experience, the most representative scenarios for robotic application include: sentinel lymph node (SLN) tracing and precise staging, especially in obese patients with endometrial cancer; complex pelvic-abdominal anatomical reconstruction due to severe intestinal adhesions or deeply infiltrating endometriosis (DIE); ureteral injury repair or reimplantation requiring delicate suturing and reconstruction; and precise anatomical dissection with vital organ protection during large uterus hysterectomy. We believe that laparoscopy serves as the foundation, while robotics acts as an important augmentation platform for miniinvasive treatment of complex surgeries. Only by combining the technical advantages of robotics with strict patient selection, team collaboration, and standardized procedures can it truly translate into patient benefits. Future implementation should emphasize indication selection, team collaboration, standardized workflow, credentialed training, and explicit safety boundaries so that the robotic platform can support high quality minimally invasive management of complex gynecologic surgery.